Patient Support

In an interview with Pharma Commerce Editor Nicholas Saraceno, Meghan Mullooly, Archbow Consulting’s Vice President, outlines the various types of available digital solutions when delivering patient services, while also sharing ways to drive efficiencies.

In the final part of his Pharma Commerce video interview, Matt Hawkins, CaryHealth’s Chief Technology Officer, comments on the importance of mitigating security risks, along with ways to take action.

In this part of his Pharma Commerce video interview, Matt Hawkins, CaryHealth’s Chief Technology Officer, outlines the necessary qualities of a digital pharmacy that will allow it to be of greatest value to patients.

A secret shopper survey study investigates how an FDA approval impacts patient access to a medication used to combat drug opioid overdose.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Matt Hawkins, CaryHealth’s Chief Technology Officer, describes how artificial intelligence can not only diagnose patients, but also deliver accurate medical advice.

Partnership adds supply chain efficiencies, while prioritizing patient safety.

In the final part of his Pharma Commerce video interview, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, defines the qualifying characteristics of a specialty lite product, and summarizes the main points of his Asembia panel.

A lack of access could shut out patients in need of maintenance drugs for complex conditions.

What does the legislation mean for patient access leaders, pharma brand managers, and patient service owners? Industry experts weigh in.

In this part of his Pharma Commerce video interview, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, discusses the impact technology has in relation to patients sticking to their medication plan.

Why the integration of AI-enabled solutions has the potential to boost patient support and engagement across numerous patient care settings.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus Access and Patient Support, outlines the main challenges surrounding medication adherence.

Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.

Will the looming changes address the concerns of the patient assistance community?

Gallagher’s 2024 US Physical & Emotional Wellbeing Report outlines ways to meeting evolving needs in the workforce.

The agreement focuses on augmenting the patient support experience, including from an adherence perspective.

A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.

In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth’s founder and CEO, discusses how patients are affected by these supply chain bottlenecks, along with ways to mitigate these complications.

Why these programs require a hybrid approach that combines technology and human connection.

An economic evaluation study assesses these costs by therapeutic class, while identifying trends in pharma R&D intensity over time.

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

A cross-sectional study evaluates the difference in clinical outcomes and demographics between pediatric RSV patients during these multiple timeframes.

A cross-sectional audit study determines how racial and ethnic disparities—among English, Mandarin, and Spanish-speaking patients—can impact access.

A longitudinal observational study examined whether the program was related to access to hospital-based services, while determining if that association differs by hospital ownership.

A retrospective study investigates whether use of these portals can be defined by clinical and sociodemographic data.

The Hopewell facility—which will serve as the CDMO’s North American hub—is expected to help accelerate the cell and gene therapy delivery process.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses ways that changes made to reimbursement models are affecting patient therapies in the biosimilar space.

A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.

A cohort study explores the connection between the rise in Medicare Advantage plan coverage and enrollee satisfaction.

By marrying real-world evidence and AI, pharma stakeholders can identify new opportunities to tailor interventions in a way that is most impactful to patients—helping them overcome roadblocks in initiating and maintaining therapy.